• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Alexion, AstraZeneca Rare Disease, Baar, Switzerland

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 3 of 3

  • Page:
  • 1

Effectiveness and Safety of Ravulizumab in Generalized Myasthenia Gravis (gMG): Updated Analysis from a Global Registry

Author:Narayanaswami, Pushpa   Pulley, Michael   Macwan, Samir   Winkley, James   Zeinali, Lida   Liu, Chuang   Juel, Vern   Tandan, Rup   Sacca, Francesco   Gordon, Andrew   Howard, James   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.014  

Author Institution:Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA  University of Florida, Jacksonville, FL  Eisenhower Health Center, Rancho Mirage, CA  Baptist Health Medical Group Neurology, Lexington, KY  Alexion, AstraZeneca Rare Disease, Mississauga, ON, Canada  Alexion, AstraZeneca Rare Disease, Baar, Switzerland  Duke University, Durham, NC  University of Vermont Medical Center, Burlington, VT  University of Naples Federico II, Napoli, Italy  Northwest Neurology, Ltd., Lake Barrington, IL  The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC  

  • View Abstract
  • View Disclosure

Assessment of Hospitalizations in Patients with Generalized Myasthenia Gravis (gMG) Before and During Treatment with Ravulizumab: Results from a Global Registry

Author:Tandan, Rup   Macwan, Samir   Winkley, James   Scheiner, Christopher   Nicolle, Michael   Zeinali, Lida   Liu, Chuang   Cutter, Gary   Habib, Ali   Pulley, Michael   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.016  

Author Institution:University of Vermont Medical Center, Burlington, VT  Eisenhower Health Center, Rancho Mirage, CA  Baptist Health Medical Group Neurology, Lexington, KY  University of Tennessee Medical Center, Knoxville, TN  London Health Sciences Centre, London, ON, Canada  Alexion, AstraZeneca Rare Disease, Mississauga, ON, Canada  Alexion, AstraZeneca Rare Disease, Baar, Switzerland  University of Alabama at Birmingham, Birmingham, AL  University of California, Irvine, Irvine, CA  University of Florida, Jacksonville, FL  

  • View Abstract
  • View Disclosure

Change in Concomitant Immunosuppressive Therapies for Generalized Myasthenia Gravis in Patients Receiving Complement C5 Inhibitor Therapies: A Retrospective Analysis of Registry Data

Author:Nowak, Richard   Habib, Ali   Scheiner, Christopher   Zeinali, Lida   Pulley, Michael   Liu, Chuang   Gordon, Andrew   Narayanaswami, Pushpa   

Session Name:P7: Neuromuscular and Clinical Neurophysiology (EMG): Neuromuscular Junction Disorders 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P7.028  

Author Institution:Yale School of Medicine, New Haven, CT  University of California, Irvine, Irvine, CA  University of Tennessee Medical Center, Knoxville, TN  Alexion, AstraZeneca Rare Disease, Mississauga, ON, Canada  University of Florida, Jacksonville, FL  Alexion, AstraZeneca Rare Disease, Baar, Switzerland  Northwest Neurology, Ltd., Lake Barrington, IL  Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA  

  • View Abstract
  • View Disclosure

Displaying 1 - 3 of 3

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com